Ardent Health (ARDT) EBIT (2023 - 2026)

Ardent Health (ARDT) has reported EBIT for 4 consecutive years, with -$90.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, EBIT fell 60.09% year-over-year to -$90.6 million; the TTM figure through Mar 2026 stood at -$518.3 million (up 21.62% YoY), while the FY2025 annual figure was -$796.6 million, down 18.88% from the prior year.
• EBIT came in at -$90.6 million for Q1 2026 at Ardent Health, up from -$185.2 million in the prior quarter.
• The five-year high for EBIT was $300.8 million in Q4 2023, with the low at -$511.0 million in Q4 2024.
• Average EBIT over 4 years is -$100.0 million, with a median of -$69.7 million recorded in 2023.
• Across the five-year window, EBIT sank 269.89% in 2024 and jumped 71.89% in 2025, its largest moves.
• Year by year, EBIT stood at $300.8 million in 2023, then tumbled by 269.89% to -$511.0 million in 2024, then soared by 63.77% to -$185.2 million in 2025, then soared by 51.09% to -$90.6 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered -$90.6 million, -$185.2 million, and -$200.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.